178 related articles for article (PubMed ID: 28977521)
1. The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.
Schosser A; Carlberg L; Calati R; Serretti A; Massat I; Spindelegger C; Linotte S; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
Int J Neuropsychopharmacol; 2017 Oct; 20(10):782-787. PubMed ID: 28977521
[TBL] [Abstract][Full Text] [Related]
2. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
[TBL] [Abstract][Full Text] [Related]
4. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Int Clin Psychopharmacol; 2016 Jan; 31(1):1-7. PubMed ID: 26544898
[TBL] [Abstract][Full Text] [Related]
5. Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression.
Carlberg L; Schosser A; Calati R; Serretti A; Massat I; Papageorgiou K; Kocabas NA; Mendlewicz J; Zohar J; Montgomery SA; Souery D; Kasper S
Int J Neurosci; 2015 May; 125(5):336-43. PubMed ID: 24955721
[TBL] [Abstract][Full Text] [Related]
6. The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.
Höfer P; Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Konstantinidis A; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
Eur Arch Psychiatry Clin Neurosci; 2013 Aug; 263(5):385-91. PubMed ID: 23081704
[TBL] [Abstract][Full Text] [Related]
7. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
Perroud N; Aitchison KJ; Uher R; Smith R; Huezo-Diaz P; Marusic A; Maier W; Mors O; Placentino A; Henigsberg N; Rietschel M; Hauser J; Souery D; Kapelski P; Bonvicini C; Zobel A; Jorgensen L; Petrovic A; Kalember P; Schulze TG; Gupta B; Gray J; Lewis CM; Farmer AE; McGuffin P; Craig I
Neuropsychopharmacology; 2009 Nov; 34(12):2517-28. PubMed ID: 19641488
[TBL] [Abstract][Full Text] [Related]
8. Antisuicidal effect, BDNF Val66Met polymorphism, and low-dose ketamine infusion: Reanalysis of adjunctive ketamine study of Taiwanese patients with treatment-resistant depression (AKSTP-TRD).
Chen MH; Lin WC; Wu HJ; Cheng CM; Li CT; Hong CJ; Tu PC; Bai YM; Tsai SJ; Su TP
J Affect Disord; 2019 May; 251():162-169. PubMed ID: 30925267
[TBL] [Abstract][Full Text] [Related]
9. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
Licinio J; Dong C; Wong ML
Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
[TBL] [Abstract][Full Text] [Related]
10. Association of BDNF Val66Met Polymorphism and Brain BDNF Levels with Major Depression and Suicide.
Youssef MM; Underwood MD; Huang YY; Hsiung SC; Liu Y; Simpson NR; Bakalian MJ; Rosoklija GB; Dwork AJ; Arango V; Mann JJ
Int J Neuropsychopharmacol; 2018 Jun; 21(6):528-538. PubMed ID: 29432620
[TBL] [Abstract][Full Text] [Related]
11. Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode.
Musil R; Zill P; Seemüller F; Bondy B; Meyer S; Spellmann I; Bender W; Adli M; Heuser I; Fisher R; Gaebel W; Maier W; Rietschel M; Rujescu D; Schennach R; Möller HJ; Riedel M
Eur Neuropsychopharmacol; 2013 Jul; 23(7):663-74. PubMed ID: 23063133
[TBL] [Abstract][Full Text] [Related]
12. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
[TBL] [Abstract][Full Text] [Related]
13. BDNF promoter methylation and suicidal behavior in depressive patients.
Kang HJ; Kim JM; Lee JY; Kim SY; Bae KY; Kim SW; Shin IS; Kim HR; Shin MG; Yoon JS
J Affect Disord; 2013 Nov; 151(2):679-685. PubMed ID: 23992681
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the BDNF and BDNFOS genes are associated with hypothalamus-pituitary axis regulation in major depression.
Hennings JM; Kohli MA; Uhr M; Holsboer F; Ising M; Lucae S
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109686. PubMed ID: 31295515
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response.
Domschke K; Lawford B; Laje G; Berger K; Young R; Morris P; Deckert J; Arolt V; McMahon FJ; Baune BT
Int J Neuropsychopharmacol; 2010 Feb; 13(1):93-101. PubMed ID: 19236730
[TBL] [Abstract][Full Text] [Related]
17. No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.
Musil R; Zill P; Seemüller F; Bondy B; Obermeier M; Spellmann I; Bender W; Adli M; Heuser I; Zeiler J; Gaebel W; Maier W; Rietschel M; Rujescu D; Schennach R; Möller HJ; Riedel M
Eur Arch Psychiatry Clin Neurosci; 2013 Aug; 263(5):405-12. PubMed ID: 22965830
[TBL] [Abstract][Full Text] [Related]
18. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study.
Perlis RH; Purcell S; Fava M; Fagerness J; Rush AJ; Trivedi MH; Smoller JW
Arch Gen Psychiatry; 2007 Jun; 64(6):689-97. PubMed ID: 17548750
[TBL] [Abstract][Full Text] [Related]
19. The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression.
Nikolac Perkovic M; Gredicak M; Sagud M; Nedic Erjavec G; Uzun S; Pivac N
Expert Rev Mol Diagn; 2023 Apr; 23(4):283-296. PubMed ID: 37038358
[TBL] [Abstract][Full Text] [Related]
20. Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.
Suchanek R; Owczarek A; Kowalczyk M; Kucia K; Kowalski J
J Mol Neurosci; 2011 Mar; 43(3):524-30. PubMed ID: 21103954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
